The following license files are associated with this item:
- QMRO Home
- Barts Cancer Institute
- Centre for Molecular Oncology
- Optimized Anchor-Modified Peptides Targeting Mutated RAS Are Promising Candidates for Immunotherapy
Browse
Administrators only